161 related articles for article (PubMed ID: 27046441)
1. Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature.
Dyba J; Tinmouth A; Bredeson C; Matthews J; Allan DS
Transfus Med; 2016 Jun; 26(3):202-7. PubMed ID: 27046441
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
[TBL] [Abstract][Full Text] [Related]
3. Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.
Fujimi A; Kamihara Y; Hashimoto A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Ono K; Iyama S; Kato J
Int J Hematol; 2015 Oct; 102(4):471-6. PubMed ID: 25964100
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
[TBL] [Abstract][Full Text] [Related]
5. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children.
Li S; Wu R; Wang B; Fu L; Zhu G; Zhou X; Ma J; Zhang L; Qin M
J Pediatr Hematol Oncol; 2019 Jan; 41(1):38-41. PubMed ID: 30080752
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
Rivera D; Bastida JM; Lopez-Corral L; Sanchez-Guijo F; Cabrero M; Martin A; Perez E; Lopez-Parra M; Avendaño A; Veiga A; Baile M; Arratibel N; Carrillo J; Vazquez L; Caballero MD; Gonzalez-Porras JR
Bone Marrow Transplant; 2019 May; 54(5):757-761. PubMed ID: 30356164
[No Abstract] [Full Text] [Related]
8. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
Bone Marrow Transplant; 2021 Oct; 56(10):2471-2476. PubMed ID: 34108675
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients.
Ahn HJ; Byun JM; Kim I; Youk J; Koh Y; Shin DY; Hong J; Yoon SS
J Korean Med Sci; 2022 Feb; 37(6):e48. PubMed ID: 35166084
[TBL] [Abstract][Full Text] [Related]
11. Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?
Huan Ng C; Jang-Milligan F; Schultz KR
Pediatr Hematol Oncol; 2021 Aug; 38(5):417-419. PubMed ID: 34157932
[No Abstract] [Full Text] [Related]
12. Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia.
Gao F; Zhou X; Shi J; Luo Y; Tan Y; Fu H; Lai X; Yu J; Huang H; Zhao Y
Ann Hematol; 2020 Nov; 99(11):2679-2687. PubMed ID: 32519094
[TBL] [Abstract][Full Text] [Related]
13. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series.
Kowalczyk M; Rubinstein PG; Aboulafia DM
J Int Assoc Provid AIDS Care; 2015; 14(3):211-6. PubMed ID: 25504472
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag Add-on Treatment in a Child With Fanconi Aplastic Anemia Awaiting Hematopoietic Stem Cell Transplantation.
Aydin Koker S; Çalişkan Polat A
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e74-e76. PubMed ID: 33560087
[TBL] [Abstract][Full Text] [Related]
16. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
[TBL] [Abstract][Full Text] [Related]
17. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia.
Bostankolu Değirmenci B; Yegin ZA; Dikyar A; Aydın Kaynar L; Özkurt ZN; Uyar Göçün P; Akyürek N
Leuk Res; 2022 Jul; 118():106870. PubMed ID: 35665626
[TBL] [Abstract][Full Text] [Related]
18. Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation.
Pasvolsky O; Shargian L; Rozovski U; Wolach O; Ram R; Shapira MY; Avni B; Stepensky P; Israeli M; Vidal-Fisher L; Shpilberg O; Raanani P; Yeshurun M
Leuk Lymphoma; 2021 Nov; 62(11):2747-2754. PubMed ID: 34013829
[TBL] [Abstract][Full Text] [Related]
19. Successful use of eltrombopag in a child with refractory immune thrombocytopenia: case study and literature review.
Wang XL; Li AM
Blood Coagul Fibrinolysis; 2016 Oct; 27(7):825-827. PubMed ID: 26650460
[TBL] [Abstract][Full Text] [Related]
20. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]